MHRA suspends recruitment to COVID-19 hydroxychloroquine trials, MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) has instructed UK clinical trialists using hydroxychloroquine to treat or prevent coronavirus (COVID-19) to suspend recruitment of further participants.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news